How Much Did Medrio Raise?
Funding & Key Investors

Medrio, a cornerstone in the eClinical software sector, has successfully navigated multiple capital cycles to solidify its market presence. With a cumulative capital infusion reaching $34M, the firm has demonstrated consistent growth trajectory. The most recent strategic investment of $2M underscores the company's resilience and its ongoing commitment to scaling its enterprise-level software-as-a-service platform within the competitive clinical research landscape.

What is Medrio?

Medrio
SoftwareHealthcare Software

Founded in 2005 and headquartered in San Francisco, Medrio provides an integrated eClinical software-as-a-service platform designed to streamline the complexities of clinical trials. By digitizing data collection and management, the company enables research organizations to accelerate study timelines and improve data integrity. Medrio occupies a critical niche in the healthcare technology ecosystem, serving as a bridge between traditional clinical research methodologies and modern, cloud-based digital transformation. Its platform is engineered to support the rigorous demands of pharmaceutical, biotech, and medical device companies, positioning the firm as a vital infrastructure provider in the global life sciences market.

How much funding has Medrio raised?

Medrio has raised a total of $34M across 3 funding rounds:

2011

Private Equity

$2M

2017

Private Equity

$30M

2020

Debt

$2M

Private Equity (2011): $2M, investors not publicly disclosed

Private Equity (2017): $30M led by Questa Capital Management

Debt (2020): $2M supported by PPP

Key Investors in Medrio

Questa Capital Management

Questa Capital invests in innovative healthcare companies that aim to enhance patient experiences, reduce costs, and improve overall population health. They partner with exceptional teams to support the development of next-generation healthcare solutions.

PPP

Public-Private Partnership

Undisclosed Investors

Undisclosed Investors

What's next for Medrio?

Following the recent strategic financing, Medrio is well-positioned to deepen its penetration into the enterprise clinical trial market. The company's roadmap likely involves enhancing its SaaS capabilities to address emerging challenges in decentralized clinical trials and real-world evidence generation. By leveraging its established reputation and historical backing, Medrio is poised to expand its footprint, potentially through product innovation or strategic market consolidation. As the industry shifts toward more agile, data-centric research models, Medrio's focus on scalable, user-friendly technology will be instrumental in maintaining its competitive advantage and driving long-term value for its stakeholders.

See full Medrio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Engineering SoftwareSoftwareContent & Collaboration Software
Financial SoftwareSoftware
Multimedia, Games & Graphics SoftwareSoftwareMobile App Development
Content & Collaboration SoftwareSoftwareMultimedia, Games & Graphics Software

Frequently Asked Questions Regarding Medrio Financial Insights

What are the most recent funding rounds that Medrio has completed, and what were the funding rounds?
Medrio has recently completed 3 funding rounds: Debt on Apr 27, 2020, Private Equity on May 11, 2017, Private Equity on Oct 12, 2011.
What is the total amount of funding Medrio has raised to date?
Medrio has raised a total of $34M in funding to date.
How many funding rounds has Medrio completed?
Medrio has completed 3 funding rounds.
How much funding did Medrio raise in its most recent funding round?
Medrio raised $2M in its most recent funding round.
Who are the lead investors in Medrio's latest funding round?
The lead investor in Medrio's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Medrio's history?
The largest funding round in Medrio's history was $30M.
See more information about Medrio